Federal hemp rewrite sets different fates for delta-8 and CBD

Delta-8 falls outside the new hemp definition

Delta-8 THC products lose federal hemp status because the revised definition excludes cannabinoids synthesized outside the plant. Congress wrote the change into H.R. 5371, the stopgap spending package President Donald Trump signed on Nov. 12, 2025, and the agriculture section of that bill rewrote the hemp definition set by the 2018 Farm Bill.

Most commercial delta-8 is made by chemically converting CBD in a lab. Under the revised text, that manufacturing route is the problem. Big change.

CBD survives, but under a strict THC ceiling

CBD itself isn't banned, but finished products face a cap of 0.4 milligrams of total THC per container. The statute counts THCA toward that total. A product can't pass by testing only for delta-9 THC.

The cap applies per container. Not per serving, and not by percentage of weight. Many full-spectrum CBD tinctures and gummies carry more THC than that. Isolate and some broad-spectrum products are better positioned, though each formulation needs its own test results.

The split turns on how a molecule is made as much as how much THC a product holds: delta-8 is excluded by its origin, while CBD is judged by its THC residue.

The provision came through appropriations, not a farm bill

Lawmakers moved the hemp change through a must-pass spending vehicle rather than a standalone bill. Sen. Mitch McConnell, R-Ky., authored the hemp language in the Senate agriculture appropriations text. Kentucky was an early hemp-growing state under the 2018 Farm Bill.

Attaching the language to a shutdown-ending package limited floor debate on the definition. That route is also why the rule reached operators with a built-in one-year runway rather than a rulemaking.

A 365-day clock is running

The new definition takes effect one year after enactment, on Nov. 12, 2026. Products that fall outside it would no longer qualify as hemp under federal law after that date.

The statute doesn't require a federal agency to finalize a rule first, which leaves enforcement posture from the FDA and DEA as the variable operators can't yet model. Congress could also change the date before then, though no change has taken effect.

What operators and investors should check now

Hemp processors and retailers should audit each SKU for synthesized cannabinoids and total THC per container before the deadline. Delta-8 lines face existential risk. CBD lines face a reformulation and testing question.

The distinction also matters for licensed markets. Adult-use states such as California and Ohio may see demand migrate from hemp shelves to dispensaries. That's a reasonable read, not a forecast.

For full background on this story, see the CannIntel topic hub on the federal hemp loophole. This report relies on the statute and MJBizDaily's headline framing, so counsel should review product-level questions.

Watch next for any bill or appropriations rider to move the Nov. 12, 2026 date, and for any FDA or DEA guidance on enforcement before it arrives.